- Investing Ideas
- /
- Swedish Biotech Stocks
Swedish Biotech Stocks
Results
55
Even though biotechnology stocks can be very risky, they can also offer some of the biggest rewards with huge profits on offer when you find the right one. The companies below all have reasonable balance sheets and value, giving the best chance of finding a gem.
55 companies
Abera Bioscience
Market Cap: SEK 81.4m
A platform and vaccine development company, research, design, and develops vaccines and immunotherapies based on its proprietary vaccine delivery platform in Sweden and internationally.
ABERA
SEK 5.30
7D
17.0%
1Y
7.9%
Biovica International
Market Cap: SEK 78.2m
A biotech company, develops and commercializes novel blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in the United States of America.
BIOVIC B
SEK 0.80
7D
-14.4%
1Y
-63.6%
Nanologica
Market Cap: SEK 75.3m
A nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.
NICA
SEK 0.85
7D
-24.6%
1Y
-86.1%
Biosergen
Market Cap: SEK 70.4m
A biotech company, develops antifungal products.
BIOSGN
SEK 0.30
7D
-9.4%
1Y
-29.1%
Inhalation Sciences Sweden
Market Cap: SEK 65.8m
Inhalation Sciences Sweden AB (publ) develops and sells labtech equipment for inhalation research.
ISAB
SEK 4.34
7D
0%
1Y
24.4%
AcouSort
Market Cap: SEK 55.6m
A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies.
ACOU
SEK 3.72
7D
-3.9%
1Y
-68.9%
Sprint Bioscience
Market Cap: SEK 45.0m
A pharmaceutical company, engages in the development of pharmaceutical products in the areas of cancer in Sweden.
SPRINT
SEK 0.64
7D
-6.3%
1Y
-52.3%
Modus Therapeutics Holding
Market Cap: SEK 44.7m
A biotechnology company, develops a treatment for sepsis and septic shock in Sweden.
MODTX
SEK 1.25
7D
-4.2%
1Y
15.8%
ODI Pharma
Market Cap: SEK 42.7m
A pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe.
ODI
SEK 2.68
7D
18.6%
1Y
-46.2%
Chosa Oncology
Market Cap: SEK 34.4m
Develops oncology drugs for the treatment of cancer.
CHOSA
SEK 0.53
7D
0%
1Y
-59.2%
Respiratorius
Market Cap: SEK 28.6m
A research company, develops drug candidates for the treatment of cancer, chronic obstructive pulmonary disease (COPD), and asthma.
RESP
SEK 5.60
7D
0.9%
1Y
n/a
Genetic Analysis
Market Cap: NOK 29.4m
A science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally.
GEAN
NOK 0.59
7D
-15.0%
1Y
-64.4%
Stayble Therapeutics
Market Cap: SEK 25.8m
Develops injectable treatment for chronic pain triggered by disc degeneration.
STABL
SEK 0.50
7D
-0.2%
1Y
107.9%
Level Bio
Market Cap: SEK 23.1m
Designs, develops, and distributes diagnostics products in the Nordic region and internationally.
LEVBIO
SEK 0.34
7D
-2.0%
1Y
17.4%
Lipigon Pharmaceuticals
Market Cap: SEK 17.6m
Develops drugs for lipid related diseases in Sweden.
LPGO
SEK 0.12
7D
0.3%
1Y
-60.6%
Spermosens
Market Cap: SEK 12.2m
Provides diagnostic health care products and services in Sweden.
SPERM
SEK 0.009
7D
2.3%
1Y
-94.5%
DanCann Pharma
Market Cap: DKK 4.8m
A biopharmaceutical company, focuses on discovering, developing, manufacturing, and commercializing therapeutic cannabinoids in various disease areas.
DANCAN
DKK 1.21
7D
-24.4%
1Y
-95.3%
Eevia Health Oyj
Market Cap: SEK 6.5m
Produces and distributes organic bioactive plant extracts in Finland and internationally.
EEVIA
SEK 0.096
7D
-13.3%
1Y
-94.4%
Scandion Oncology
Market Cap: SEK 2.9m
A clinical-stage biotechnology company, develops medicines for the treatment of cancer.
SCOL
SEK 0.013
7D
33.0%
1Y
-99.5%